focus -WSS

focus

author：fashion 2025-09-27 17:02:53 - browse：3

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Pancreatic cancer early detection could be helped by AI

focus

WSS

Syphilis numbers in the United States reach record heights

STAT Virtual Event: Putting AI to the Test

What Congress can do to address the rural doctor shortage

Investment in vaccine development is lagging, report finds

Microbiome research is starting to find links to chronic diseases

Zyn nicotine pouches become unlikely player in latest culture war

hotspot

focus

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biogen walks away from Aduhelm, years after polarizing approval

In age of alternative facts, a scholarly course on calling out crap

White House pharmacy plagued with problems, investigation finds

BioMarin wins approval for gene therapy to treat hemophilia A

Biogen walks away from Aduhelm, years after polarizing approval

Malaria cases in Florida and Texas: Here’s what you need to know

Biogen walks away from Aduhelm, years after polarizing approval

Duchenne breakthrough therapy leaves behind pioneering families

Pancreatic cancer early detection could be helped by AI

Wikipedia

Medical student insurance fails on mental health care coverage

Venture capital firm's plans to take over Akron hospital face hurdles

Pancreatic cancer early detection could be helped by AI

Health Care Service Corp to buy Cigna Medicare Advantage plans

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

Merck CEO won’t testify in Senate, citing no expertise in drug prices

focus

hotspot

focus

focus